RE
REGN
-0.5%🟢 Fundamentally supportedRegeneron Pharmaceuticals Inc. · Healthcare
$792.00Vol 654.0K · 0.8× normalMkt cap −$0.45BMarket closed — 2026-10-16 session
What happened
Move
-0.5%
Price
$792.00
Volume
654.0K
0.8× normal
Market cap
$81.54B
−$0.45B today
Why it moved
Earnings releasemedium confidence
- Q2 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks — finnhub-news
- What to Expect From Regeneron Pharmaceuticals' Next Quarterly Earnings Report — finnhub-news
Possible catalyst: earnings release.
Verdict — was the move justified?
🟢 Fundamentally supported
Earnings release — direction and rough magnitude are consistent with the identified fundamental catalyst.
How unusual is this move
σ score
0.3σ
vs own 20d volatility
Percentile
29th
of 1278 daily moves
Avg daily move
±1.3%
own 5y average
vs sector
+0.6%
beyond sector median
Fundamental context
V 41G 25P 69H 100Q 69EW 33/65
Insider activity (90d): net selling $2.41M
Valuation context
P/E (TTM)
18.8
5y median 17.2
P/E percentile
64%
vs own 5y history
FCF yield
0.0%
Valuation sits near the middle of its own historical range (64th percentile).
Full fundamental analysis on PreMarketPrice
Pillar scores, financial statements, valuation history, news & more for REGN